Verrica Pharmaceuticals Ownership 2024 | Who Owns Verrica Pharmaceuticals Now?
Institutional Ownership
10.61%
Insider Ownership
34.54%
Retail Ownership
54.85%
Institutional Holders
44.00
Verrica Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 15.27% | 1.23% | 7,099,182 | - | - | 51,753,037 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 8.61% | 0.39% | 3,999,999 | - | - | 29,159,993 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.73% | 0.00% | 1,269,466 | 756 | 0.06% | 9,254,406 | Jun 30, 2024 |
| BLACKROCK INC. | 2.43% | 0.00% | 1,129,143 | 15,083 | 1.35% | 8,231,453 | Jun 30, 2024 |
| FMR LLC | 2.39% | 0.00% | 1,108,747 | -400,502 | -26.54% | 8,082,766 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 463,362 | 14,053 | 3.13% | 3,378,302 | Jun 30, 2024 |
| STATE STREET CORP | 0.97% | 0.00% | 451,780 | 39,177 | 9.50% | 3,293,476,000 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 0.91% | 2.01% | 424,937 | 424,937 | 100.00% | 3,097,791 | Jun 30, 2024 |
| INVESCO LTD. | 0.91% | 0.00% | 423,520 | 423,520 | 100.00% | 3,087,461 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.60% | 0.14% | 280,000 | 280,000 | 100.00% | 2,041,200 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 190,675 | -8,047 | -4.05% | 1,390,021,000 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.39% | 0.00% | 182,020 | -1,554 | -0.85% | 1,326,925 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 0.39% | 0.94% | 180,000 | - | - | 1,312,200 | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.26% | 0.04% | 122,836 | -15,100 | -10.95% | 895,475 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.26% | 0.00% | 119,919 | 17,534 | 17.13% | 874,210 | Jun 30, 2024 |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 0.22% | 0.01% | 100,125 | 50,000 | 99.75% | 729,911 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.20% | 0.00% | 95,032 | - | - | 692,783 | Jun 30, 2024 |
| MORGAN STANLEY | 0.18% | - | 84,939 | -49,277 | -36.71% | 619,204 | Jun 30, 2024 |
| MIRACLE MILE ADVISORS, LLC | 0.18% | 0.01% | 84,000 | -34,221 | -28.95% | 612,360 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.18% | 0.01% | 82,200 | - | - | 599,238 | Jun 30, 2024 |
Verrica Pharmaceuticals's largest institutional shareholder is PERCEPTIVE ADVISORS LLC, holding 15.27% of the company's total share outstanding, currently valued at $51.75M. The top 10 institutional shareholders own together 35.82% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROPEL BIO MANAGEMENT, LLC | 0.91% | 2.01% | 424,937 | 424,937 | 100.00% | 3,097,791 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 15.27% | 1.23% | 7,099,182 | - | - | 51,753,037 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 0.39% | 0.94% | 180,000 | - | - | 1,312,200 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 8.61% | 0.39% | 3,999,999 | - | - | 29,159,993 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.60% | 0.14% | 280,000 | 280,000 | 100.00% | 2,041,200 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.15% | 0.08% | 70,586 | 70,586 | 100.00% | 514,572 | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.26% | 0.04% | 122,836 | -15,100 | -10.95% | 895,475 | Jun 30, 2024 |
| SPC FINANCIAL, INC. | 0.06% | 0.02% | 30,000 | - | - | 218,700 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.02% | 0.02% | 9,415 | 9,415 | 100.00% | 68,635 | Jun 30, 2024 |
| MIRACLE MILE ADVISORS, LLC | 0.18% | 0.01% | 84,000 | -34,221 | -28.95% | 612,360 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.18% | 0.01% | 82,200 | - | - | 599,238 | Jun 30, 2024 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 0.16% | 0.01% | 74,251 | - | - | 541,290 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 6,926 | 6,926 | 100.00% | 50,491 | Jun 30, 2024 |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 0.22% | 0.01% | 100,125 | 50,000 | 99.75% | 729,911 | Jun 30, 2024 |
| CETERA TRUST COMPANY, N.A | 0.00% | 0.00% | 1,000 | - | - | 7,290 | Jun 30, 2024 |
| BECK MACK & OLIVER LLC | 0.06% | 0.00% | 30,000 | - | - | 218,700 | Jun 30, 2024 |
| SALOMON & LUDWIN, LLC | 0.01% | 0.00% | 2,900 | - | - | 21,141 | Jun 30, 2024 |
| SPIRE WEALTH MANAGEMENT | 0.01% | 0.00% | 5,650 | - | - | 41,189 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | 0.00% | 42,794 | 17,705 | 70.57% | 311,968 | Jun 30, 2024 |
| INVESCO LTD. | 0.91% | 0.00% | 423,520 | 423,520 | 100.00% | 3,087,461 | Jun 30, 2024 |
The largest Verrica Pharmaceuticals shareholder by % of total assets is PROPEL BIO MANAGEMENT, LLC. The company owns 424.94K shares of Verrica Pharmaceuticals (VRCA), representing 2.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROPEL BIO MANAGEMENT, LLC | 0.91% | 2.01% | 424,937 | 424,937 | 100.00% | 3,097,791 | Jun 30, 2024 |
| INVESCO LTD. | 0.91% | 0.00% | 423,520 | 423,520 | 100.00% | 3,087,461 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.60% | 0.14% | 280,000 | 280,000 | 100.00% | 2,041,200 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.15% | 0.08% | 70,586 | 70,586 | 100.00% | 514,572 | Jun 30, 2024 |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 0.22% | 0.01% | 100,125 | 50,000 | 99.75% | 729,911 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.10% | 0.00% | 45,525 | 45,525 | 100.00% | 331,877 | Jun 30, 2024 |
| STATE STREET CORP | 0.97% | 0.00% | 451,780 | 39,177 | 9.50% | 3,293,476,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | 0.00% | 42,794 | 17,705 | 70.57% | 311,968 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.26% | 0.00% | 119,919 | 17,534 | 17.13% | 874,210 | Jun 30, 2024 |
| BLACKROCK INC. | 2.43% | 0.00% | 1,129,143 | 15,083 | 1.35% | 8,231,453 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 463,362 | 14,053 | 3.13% | 3,378,302 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | - | 12,200 | 12,200 | 100.00% | 88,938 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 11,892 | 11,892 | 100.00% | 86,693 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,389 | 11,389 | 100.00% | 83,026 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 10,186 | 10,186 | 100.00% | 74,256 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.02% | 0.02% | 9,415 | 9,415 | 100.00% | 68,635 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 6,926 | 6,926 | 100.00% | 50,491 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.06% | 0.00% | 26,591 | 4,514 | 20.45% | 193,838 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.13% | 0.00% | 58,680 | 4,393 | 8.09% | 427,778 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 4,690 | 3,163 | 207.14% | 34,190 | Jun 30, 2024 |
As of Jun 30 2024, Verrica Pharmaceuticals's largest institutional buyer is PROPEL BIO MANAGEMENT, LLC. The company purchased 424.94K stocks of VRCA, valued at $3.10M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 2.39% | 0.00% | 1,108,747 | -400,502 | -26.54% | 8,082,766 | Jun 30, 2024 |
| MORGAN STANLEY | 0.18% | - | 84,939 | -49,277 | -36.71% | 619,204 | Jun 30, 2024 |
| MIRACLE MILE ADVISORS, LLC | 0.18% | 0.01% | 84,000 | -34,221 | -28.95% | 612,360 | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -27,312 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -19,555 | -100.00% | - | Jun 30, 2024 |
| LEGACY TRUST | - | - | - | -18,750 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 6,343 | -15,989 | -71.60% | 46,241 | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.26% | 0.04% | 122,836 | -15,100 | -10.95% | 895,475 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -11,654 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -10,288 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 1,621 | -8,721 | -84.33% | 11,817 | Jun 30, 2024 |
| BARCLAYS PLC | 0.01% | - | 6,211 | -8,383 | -57.44% | 45,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 190,675 | -8,047 | -4.05% | 1,390,021,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.11% | 0.00% | 51,290 | -4,066 | -7.35% | 373,904 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.04% | 0.00% | 17,350 | -3,150 | -15.37% | 126,484 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,289 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.01% | - | 6,062 | -1,676 | -21.66% | 44,192 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.39% | 0.00% | 182,020 | -1,554 | -0.85% | 1,326,925 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 1,372 | -727 | -34.64% | 10,002 | Jun 30, 2024 |
As of Jun 30 2024, Verrica Pharmaceuticals's biggest institutional seller is FMR LLC. The company sold -0.40M shares of VRCA, valued at $8.08M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROPEL BIO MANAGEMENT, LLC | 0.91% | 2.01% | 424,937 | 424,937 | 100.00% | 3,097,791 | Jun 30, 2024 |
| INVESCO LTD. | 0.91% | 0.00% | 423,520 | 423,520 | 100.00% | 3,087,461 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.60% | 0.14% | 280,000 | 280,000 | 100.00% | 2,041,200 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.15% | 0.08% | 70,586 | 70,586 | 100.00% | 514,572 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.10% | 0.00% | 45,525 | 45,525 | 100.00% | 331,877 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | - | 12,200 | 12,200 | 100.00% | 88,938 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 11,892 | 11,892 | 100.00% | 86,693 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,389 | 11,389 | 100.00% | 83,026 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 10,186 | 10,186 | 100.00% | 74,256 | Jun 30, 2024 |
| KEY FINANCIAL INC | 0.02% | 0.02% | 9,415 | 9,415 | 100.00% | 68,635 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 6,926 | 6,926 | 100.00% | 50,491 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 241 | 241 | 100.00% | 1,757 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 1,458 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | - | 176 | 176 | 100.00% | 1,283 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 158 | 158 | 100.00% | 1,152 | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | 0.00% | 0.00% | 110 | 110 | 100.00% | 802 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 88 | 88 | 100.00% | 642 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 34 | 34 | 100.00% | 248 | Jun 30, 2024 |
Verrica Pharmaceuticals's largest new institutional shareholder by number of shares is PROPEL BIO MANAGEMENT, LLC, purchased 424.94K shares, valued at $3.10M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MML INVESTORS SERVICES, LLC | - | - | - | -27,312 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -19,555 | -100.00% | - | Jun 30, 2024 |
| LEGACY TRUST | - | - | - | -18,750 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -11,654 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -10,288 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,289 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -698 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Verrica Pharmaceuticals's largest sold out institutional shareholder by shares sold is MML INVESTORS SERVICES, LLC, sold -27.31K shares, valued at -, as of undefined.
Verrica Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| DEUTSCHE DWS INVESTMENT TRUST | 0.06% | 174,700 | 89,262 | 104.48% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 16,816 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 75,000 | -24,550 | -24.66% | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,508,769 | - | - | Feb 29, 2024 |
| BUFFALO FUNDS | 0.01% | 74,251 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 16,956 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 34,321 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,208 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 16,213 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,105,142 | -288,028 | -20.67% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 55,356 | - | - | Jan 31, 2024 |
| Global X Funds | 0.00% | 47,963 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 196,974 | 10,250 | 5.49% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,724 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 3,179 | 3,179 | - | Mar 28, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 7,358 | -1,526 | -17.18% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,927 | -4,029 | -36.77% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 103 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 727 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,582 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 295 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 15,551 | -1,262 | -7.51% | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 9,886 | -384 | -3.74% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,400 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,279 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,287 | 258 | 25.07% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 95,221 | 12,599 | 15.25% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 190 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 740,454 | -44,065 | -5.62% | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 105,820 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 39,636 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 2,078 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,133 | 623 | 17.75% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 95,032 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 3,417 | -12,284 | -78.24% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 8,012 | -32 | -0.40% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 94 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,081 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,357 | 583 | 21.02% | Jan 31, 2024 |
| ProFunds | 0.00% | 162 | -14 | -7.95% | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 78 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,076 | 382 | 14.18% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 12 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund II | 0.00% | 8,790 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,000 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,117 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 17,600 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,365 | -10 | -0.42% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,321 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 80 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 6,314 | 2,053 | 48.18% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 10,442 | 1,121 | 12.03% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 762 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 2,543 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 6,467 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,142 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 3,653 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,541 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,976 | 916 | 44.47% | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,416 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 1 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 4,500 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,462 | - | - | Feb 29, 2024 |
Verrica Pharmaceuticals's largest mutual fund holder by % of total assets is "DEUTSCHE DWS INVESTMENT TRUST", owning 174.70K shares, compromising 0.06% of its total assets.
Verrica Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -27.87% |
| 31 Mar, 24 | 61 | -7.58% |
| 31 Dec, 23 | 66 | -4.35% |
| 30 Sep, 23 | 69 | 4.55% |
| 30 Jun, 23 | 66 | 4.76% |
| 31 Mar, 23 | 63 | 23.53% |
| 31 Dec, 22 | 51 | 6.25% |
| 30 Sep, 22 | 48 | -11.11% |
| 30 Jun, 22 | 54 | 12.50% |
| 31 Mar, 22 | 48 | 6.67% |
| 31 Dec, 21 | 45 | -16.67% |
| 30 Sep, 21 | 54 | 1.89% |
| 30 Jun, 21 | 53 | 3.92% |
| 31 Mar, 21 | 51 | 15.91% |
| 31 Dec, 20 | 44 | -6.38% |
| 30 Sep, 20 | 47 | -2.08% |
| 30 Jun, 20 | 48 | - |
| 31 Mar, 20 | 48 | -9.43% |
| 31 Dec, 19 | 53 | 23.26% |
| 30 Sep, 19 | 43 | 4.88% |
| 30 Jun, 19 | 41 | 2.50% |
| 31 Mar, 19 | 40 | -2.44% |
| 31 Dec, 18 | 41 | -8.89% |
| 30 Sep, 18 | 45 | 60.71% |
| 30 Jun, 18 | 28 | - |
As of 30 Jun 24, 44 institutions are holding Verrica Pharmaceuticals's shares, representing a decrease of -27.87% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,931,707 | -72.21% |
| 31 Mar, 24 | 17,749,027 | -1.42% |
| 31 Dec, 23 | 18,004,540 | 19.63% |
| 30 Sep, 23 | 15,050,397 | 3.08% |
| 30 Jun, 23 | 14,600,620 | 13.01% |
| 31 Mar, 23 | 12,920,029 | 19.69% |
| 31 Dec, 22 | 10,794,200 | 5.63% |
| 30 Sep, 22 | 10,219,011 | -6.09% |
| 30 Jun, 22 | 10,881,768 | 22.48% |
| 31 Mar, 22 | 8,884,765 | -0.77% |
| 31 Dec, 21 | 8,953,453 | -2.36% |
| 30 Sep, 21 | 9,169,436 | -7.73% |
| 30 Jun, 21 | 9,937,216 | 0.10% |
| 31 Mar, 21 | 9,927,551 | 10.81% |
| 31 Dec, 20 | 8,959,178 | 0.32% |
| 30 Sep, 20 | 8,930,935 | 1.42% |
| 30 Jun, 20 | 8,806,251 | -0.31% |
| 31 Mar, 20 | 8,833,960 | -4.03% |
| 31 Dec, 19 | 9,204,887 | -0.67% |
| 30 Sep, 19 | 9,266,698 | 2.76% |
| 30 Jun, 19 | 9,018,115 | 2.28% |
| 31 Mar, 19 | 8,816,969 | 4.40% |
| 31 Dec, 18 | 8,445,153 | 2.49% |
| 30 Sep, 18 | 8,239,634 | -0.90% |
| 30 Jun, 18 | 8,314,673 | - |
Verrica Pharmaceuticals (VRCA) has 4.93M shares outstanding as of 30 Jun 24, down -72.21% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.61% | 0.69% |
| 31 Mar, 24 | 39.14% | 2.56% |
| 31 Dec, 23 | 39.08% | 3.64% |
| 30 Sep, 23 | 32.78% | 2.85% |
| 30 Jun, 23 | 33.94% | 3.76% |
| 31 Mar, 23 | 30.03% | 4.35% |
| 31 Dec, 22 | 26.27% | 4.09% |
| 30 Sep, 22 | 25.35% | 1.62% |
| 30 Jun, 22 | 39.54% | 3.79% |
| 31 Mar, 22 | 32.29% | 2.95% |
| 31 Dec, 21 | 33.11% | 2.98% |
| 30 Sep, 21 | 33.32% | 2.55% |
| 30 Jun, 21 | 36.12% | 2.40% |
| 31 Mar, 21 | 38.78% | 3.03% |
| 31 Dec, 20 | 35.75% | 2.80% |
| 30 Sep, 20 | 35.74% | 2.87% |
| 30 Jun, 20 | 35.27% | 2.82% |
| 31 Mar, 20 | 35.39% | 2.59% |
| 31 Dec, 19 | 36.93% | 2.67% |
| 30 Sep, 19 | 37.23% | 2.83% |
| 30 Jun, 19 | 36.25% | 2.88% |
| 31 Mar, 19 | 35.47% | 3.07% |
| 31 Dec, 18 | 33.99% | 3.09% |
| 30 Sep, 18 | 33.16% | 2.96% |
| 30 Jun, 18 | 33.46% | - |
As of 30 Jun 24, Verrica Pharmaceuticals is held by 10.61% institutional shareholders, representing a 0.69% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 22 | 22.22% |
| 31 Mar, 24 | 18 | -41.94% |
| 31 Dec, 23 | 31 | 6.90% |
| 30 Sep, 23 | 29 | -30.95% |
| 30 Jun, 23 | 42 | 10.53% |
| 31 Mar, 23 | 38 | 31.03% |
| 31 Dec, 22 | 29 | 45.00% |
| 30 Sep, 22 | 20 | -39.39% |
| 30 Jun, 22 | 33 | 94.12% |
| 31 Mar, 22 | 17 | -22.73% |
| 31 Dec, 21 | 22 | -4.35% |
| 30 Sep, 21 | 23 | 4.55% |
| 30 Jun, 21 | 22 | -4.35% |
| 31 Mar, 21 | 23 | 21.05% |
| 31 Dec, 20 | 19 | 58.33% |
| 30 Sep, 20 | 12 | -45.45% |
| 30 Jun, 20 | 22 | 22.22% |
| 31 Mar, 20 | 18 | -48.57% |
| 31 Dec, 19 | 35 | 59.09% |
| 30 Sep, 19 | 22 | -4.35% |
| 30 Jun, 19 | 23 | - |
| 31 Mar, 19 | 23 | -4.17% |
| 31 Dec, 18 | 24 | -27.27% |
| 30 Sep, 18 | 33 | 17.86% |
| 30 Jun, 18 | 28 | - |
22 institutional shareholders have increased their position in VRCA stock as of 30 Jun 24 compared to 18 in the previous quarter (a 22.22% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -55.00% |
| 31 Mar, 24 | 20 | 17.65% |
| 31 Dec, 23 | 17 | -10.53% |
| 30 Sep, 23 | 19 | 171.43% |
| 30 Jun, 23 | 7 | -46.15% |
| 31 Mar, 23 | 13 | 18.18% |
| 31 Dec, 22 | 11 | -21.43% |
| 30 Sep, 22 | 14 | - |
| 30 Jun, 22 | 14 | -26.32% |
| 31 Mar, 22 | 19 | 72.73% |
| 31 Dec, 21 | 11 | -8.33% |
| 30 Sep, 21 | 12 | -33.33% |
| 30 Jun, 21 | 18 | -5.26% |
| 31 Mar, 21 | 19 | 58.33% |
| 31 Dec, 20 | 12 | -50.00% |
| 30 Sep, 20 | 24 | 71.43% |
| 30 Jun, 20 | 14 | -22.22% |
| 31 Mar, 20 | 18 | 157.14% |
| 31 Dec, 19 | 7 | -22.22% |
| 30 Sep, 19 | 9 | 50.00% |
| 30 Jun, 19 | 6 | 20.00% |
| 31 Mar, 19 | 5 | -37.50% |
| 31 Dec, 18 | 8 | 14.29% |
| 30 Sep, 18 | 7 | - |
| 30 Jun, 18 | - | - |
9 institutional shareholders have reduced their position in VRCA stock as of 30 Jun 24 compared to 20 in the previous quarter (a -55.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 44 | -27.87% | 4,931,707 | -72.21% | 10.61% | 0.69% | 22 | 22.22% | 9 | -55.00% |
| 31 Mar, 24 | 61 | -7.58% | 17,749,027 | -1.42% | 39.14% | 2.56% | 18 | -41.94% | 20 | 17.65% |
| 31 Dec, 23 | 66 | -4.35% | 18,004,540 | 19.63% | 39.08% | 3.64% | 31 | 6.90% | 17 | -10.53% |
| 30 Sep, 23 | 69 | 4.55% | 15,050,397 | 3.08% | 32.78% | 2.85% | 29 | -30.95% | 19 | 171.43% |
| 30 Jun, 23 | 66 | 4.76% | 14,600,620 | 13.01% | 33.94% | 3.76% | 42 | 10.53% | 7 | -46.15% |
| 31 Mar, 23 | 63 | 23.53% | 12,920,029 | 19.69% | 30.03% | 4.35% | 38 | 31.03% | 13 | 18.18% |
| 31 Dec, 22 | 51 | 6.25% | 10,794,200 | 5.63% | 26.27% | 4.09% | 29 | 45.00% | 11 | -21.43% |
| 30 Sep, 22 | 48 | -11.11% | 10,219,011 | -6.09% | 25.35% | 1.62% | 20 | -39.39% | 14 | - |
| 30 Jun, 22 | 54 | 12.50% | 10,881,768 | 22.48% | 39.54% | 3.79% | 33 | 94.12% | 14 | -26.32% |
| 31 Mar, 22 | 48 | 6.67% | 8,884,765 | -0.77% | 32.29% | 2.95% | 17 | -22.73% | 19 | 72.73% |
| 31 Dec, 21 | 45 | -16.67% | 8,953,453 | -2.36% | 33.11% | 2.98% | 22 | -4.35% | 11 | -8.33% |
| 30 Sep, 21 | 54 | 1.89% | 9,169,436 | -7.73% | 33.32% | 2.55% | 23 | 4.55% | 12 | -33.33% |
| 30 Jun, 21 | 53 | 3.92% | 9,937,216 | 0.10% | 36.12% | 2.40% | 22 | -4.35% | 18 | -5.26% |
| 31 Mar, 21 | 51 | 15.91% | 9,927,551 | 10.81% | 38.78% | 3.03% | 23 | 21.05% | 19 | 58.33% |
| 31 Dec, 20 | 44 | -6.38% | 8,959,178 | 0.32% | 35.75% | 2.80% | 19 | 58.33% | 12 | -50.00% |
| 30 Sep, 20 | 47 | -2.08% | 8,930,935 | 1.42% | 35.74% | 2.87% | 12 | -45.45% | 24 | 71.43% |
| 30 Jun, 20 | 48 | - | 8,806,251 | -0.31% | 35.27% | 2.82% | 22 | 22.22% | 14 | -22.22% |
| 31 Mar, 20 | 48 | -9.43% | 8,833,960 | -4.03% | 35.39% | 2.59% | 18 | -48.57% | 18 | 157.14% |
| 31 Dec, 19 | 53 | 23.26% | 9,204,887 | -0.67% | 36.93% | 2.67% | 35 | 59.09% | 7 | -22.22% |
| 30 Sep, 19 | 43 | 4.88% | 9,266,698 | 2.76% | 37.23% | 2.83% | 22 | -4.35% | 9 | 50.00% |
| 30 Jun, 19 | 41 | 2.50% | 9,018,115 | 2.28% | 36.25% | 2.88% | 23 | - | 6 | 20.00% |
| 31 Mar, 19 | 40 | -2.44% | 8,816,969 | 4.40% | 35.47% | 3.07% | 23 | -4.17% | 5 | -37.50% |
| 31 Dec, 18 | 41 | -8.89% | 8,445,153 | 2.49% | 33.99% | 3.09% | 24 | -27.27% | 8 | 14.29% |
| 30 Sep, 18 | 45 | 60.71% | 8,239,634 | -0.90% | 33.16% | 2.96% | 33 | 17.86% | 7 | - |
| 30 Jun, 18 | 28 | - | 8,314,673 | - | 33.46% | - | 28 | - | - | - |
Verrica Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Verrica Pharmaceuticals's stock was made by White Ted on Jul 23 2024, selling 32,469 shares at $7.06 per share (valued at $229.23K).
Verrica Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | 4 | - | - |
| Q1 2024 | 10 | - | - |
| Q4 2023 | 9 | 10 | 90.00% |
| Q3 2023 | 10 | 4 | 250.00% |
| Q2 2023 | 4 | - | - |
| Q1 2023 | 5 | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 7 | - | - |
| Q1 2022 | 5 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 11 | - | - |
| Q1 2021 | 6 | - | - |
| Q3 2020 | 13 | 1 | 1300.00% |
| Q2 2020 | 4 | 1 | 400.00% |
| Q1 2020 | 5 | 2 | 250.00% |
| Q4 2019 | 4 | - | - |
| Q3 2019 | - | 37 | - |
| Q2 2019 | 4 | 56 | 7.14% |
0 total buy trades, and 8 total sell trades (buy/sell ratio of 0.00%) were made by Verrica Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 9 | 10 | 90.00% |
| Q3 2023 | 1 | 4 | 25.00% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 3 | - | - |
| Q1 2021 | 1 | - | - |
| Q3 2020 | 11 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 3 | - | - |
| Q3 2019 | - | 37 | - |
| Q2 2019 | - | 56 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Verrica Pharmaceuticals's stocks.
Verrica Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| VIGL | Vigil Neuroscience, Inc. |
| NUVB | Nuvation Bio Inc. |
| IVA | Inventiva S.A. |
| LRMR | Larimar Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ARQT | Arcutis Biotherapeutics, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| LIAN | LianBio |
| KDNY | Chinook Therapeutics, Inc. |
| ETON | Eton Pharmaceuticals, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| ASND | Ascendis Pharma A/S |
| ELDN | Eledon Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| FIXX | Q32 Bio Inc. |
| VRNA | Verona Pharma plc |
| GRTX | Galera Therapeutics, Inc. |
VRCA Ownership FAQ
Who Owns Verrica Pharmaceuticals?
Verrica Pharmaceuticals is owned by institutional shareholders (10.61%), insiders (34.54%), and public (54.85%). The largest institutional shareholder of Verrica Pharmaceuticals is PERCEPTIVE ADVISORS LLC (15.27% of total shares) and the top mutual fund owner is DEUTSCHE DWS INVESTMENT TRUST (0.06% of total shares).
Who are the major institutional shareholders of Verrica Pharmaceuticals?
Verrica Pharmaceuticals's major institutional shareholders are PERCEPTIVE ADVISORS LLC, AVORO CAPITAL ADVISORS LLC, VANGUARD GROUP INC, BLACKROCK INC., and FMR LLC. The top five shareholders own together 31.42% of the company's share outstanding.
How many Verrica Pharmaceuticals shareholders are there?
As of Jun 2024, there are 44 institutional shareholders of Verrica Pharmaceuticals.
What percentage of Verrica Pharmaceuticals is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC owns 7.1M shares of Verrica Pharmaceuticals, representing 15.27% of the company's total shares outstanding, valued at $51.75M (as of Jun 2024).
What percentage of Verrica Pharmaceuticals is owned by AVORO CAPITAL ADVISORS LLC?
As of Jun 2024, AVORO CAPITAL ADVISORS LLC holds 4M shares of Verrica Pharmaceuticals (VRCA), compromising 8.61% of the company, valued at $29.16M.
What percentage of Verrica Pharmaceuticals is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Verrica Pharmaceuticals. The company owns 1.27M of the company's shares outstanding (worth $9.25M).